Status:
UNKNOWN
Immune Responses and Immunological Tolerance After Rabies Booster Vaccination in HIV-infected Adults
Lead Sponsor:
Queen Saovabha Memorial Institute
Conditions:
Rabies
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
To study the humoral and cell-mediated immune responses in HIV-infected adults who had previously received rabies booster vaccination more than a year before
Detailed Description
Previous study has shown the higher immunogenicity response among HIV-infected adults who received a single visit 4-site intradermal rabies booster vaccination than those who received the conventional...
Eligibility Criteria
Inclusion
- Healthy HIV-infected adults
- Previously received rabies booster vaccination by participation in the previous clinical trials of the investigators.
Exclusion
- Have any active opportunistic infections
- Received blood or blood product within 3 months
- Received anti-malarial drugs
- Received rabies vaccination in a previous year.
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03228069
Start Date
August 1 2017
End Date
December 1 2023
Last Update
April 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Saovabha Memorial Institute
Bangkok, Thailand, 10330